Amrutanjan Health Care Ltd

Amrutanjan Health Care Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 June 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Amrutanjan Health Care Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. The stock’s recent performance, combined with mixed signals from MACD, RSI, and moving averages, suggests increased caution for investors amid a challenging market backdrop.

Amrutanjan Health Care Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 09 June 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Amrutanjan Health Care Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 May 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Amrutanjan Health Care Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 17 May 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Amrutanjan Health Care Ltd., the Chennai-based pain relief and wellness products manufacturer, delivered a mixed performance in Q4 FY26 (Mar'26), with net profit rising to ₹16.19 crores—a sequential increase of 6.67% from Q3 FY26 but a modest year-on-year growth of 6.65% from ₹15.18 crores in Mar'25. The company's market capitalisation stands at ₹1,598 crores, with shares trading at ₹548.80 as of May 08, 2026, down 1.75% on the day and 17.86% year-to-date.

Amrutanjan Health Care Ltd has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a 2.74% gain on 7 May 2026, the stock’s momentum indicators and moving averages suggest a cautious outlook for investors navigating this small-cap pharmaceutical player’s evolving trend.

Amrutanjan Health Care Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Amrutanjan Health Care Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to a more pronounced bearish trend. The stock’s recent 7.54% decline to ₹533.50, coupled with downgrades in its technical grades and a revised Mojo Grade from Buy to Hold, reflects growing caution among investors amid mixed signals from momentum oscillators and moving averages.

Amrutanjan Health Care Ltd experienced significant intraday weakness on 5 May 2026, with the stock touching a low of Rs 532, marking a 7.8% decline from previous levels. The pharmaceutical company underperformed its sector and the broader market amid heightened volatility and persistent selling pressure.

Amrutanjan Health Care Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 April 2026, providing investors with an up-to-date perspective on its performance and outlook.

Amrutanjan Health Care Ltd has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals. Despite a recent 3.94% rise in the stock price to ₹564.55, the overall technical trend has softened from bearish to mildly bearish, prompting a downgrade in its Mojo Grade from Buy to Hold as of 18 Nov 2025.

Amrutanjan Health Care Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Amrutanjan Health Care Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 03 April 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Amrutanjan Health Care Ltd’s share price declined to a fresh 52-week low of Rs.495.25 on 30 March 2026, marking a significant downturn amid broader market volatility and sector underperformance. The stock has experienced a notable slide over recent sessions, reflecting a combination of valuation pressures and subdued growth metrics.

Amrutanjan Health Care Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Amrutanjan Health Care Ltd’s share price declined to a fresh 52-week low of Rs 500 on 23 March 2026, marking a significant downturn amid broader market weakness and sectoral pressures. The stock’s performance reflects a continuation of recent trends, with the price retreating below key moving averages and underperforming its benchmark indices over the past year.